I am afraid I will not be able to participate in the next TC re: OERC due to a medical appointment that had to be made at short notice. Please accept my apologies.
I did have a few thoughts about the teaming agreement which are as follows:
Might be useful to have some introductory statements about each of the involved partners and why a teaming agreement would be valuable.
The “solution: offered is MedicalBridge, although iPath is mentioned as being “exposed” within Medical Bridge. Being unfamiliar with MedicalBridge, I do not understand this. It also tends to “beg the question” as to why a teaming agreement is required – hence the need to justify this. It might be useful for the non-informatician to give a brief outline of MedicalBridge in layman’s language.
The need for “content” relevant to the countries with limited resources might be emphasized.
How does “Medical Bridge” differ in concept from caBIG, and to what extent does it complement caBIG or could it be made interoperable with caBIG elements? This could be a question asked by NIH given the funding already expended on caBIG.
Hope this is helpful,
International Network for Cancer Treatment and Research